U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the start ...

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...

This recovery should alleviate concerns about dividend sustainability and provide the financial flexibility needed for strategic investments. From a valuation perspective, Pfizer's stock is highly ...

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

A recent report released by Oliver Wyman ... Rather than expecting specialist sustainability teams within companies to drive change across the whole business, the consulting firm recommends ...

REA Group says it’s ‘disappointed’ and ‘frustrated’ by rejections.   08:43 Nelson Peltz’s Trian Partners has ...

In today’s fast-paced world, finding the right marketing agency can feel overwhelming. With so many options, it’s ...

Starboard Value reportedly has taken a roughly $1 billion stake in Pfizer, as the activist investor seeks to turn the ...

Pfizer (PFE) shares were up 4% Monday morning in the wake of reports that activist investor Starboard Value had taken a ...

Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. Monitor ...

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...